Why Is MOTS-c Considered a "Longevity" Research Peptide?

Aged mouse models are a standard tool in longevity research, and published MOTS-c studies in this population have documented reduced age-related metabolic dysfunction alongside increased mitochondrial biogenesis and exercise capacity — outcomes that place MOTS-c alongside other AMPK-pathway-linked compounds studied in the aging-research field.

The AMPK pathway MOTS-c activates is the same general pathway implicated in the well-studied benefits of caloric restriction and, separately, in metformin's researched effects — this mechanistic overlap is the primary reason MOTS-c earned a place in longevity-research discussion rather than being classified purely as a metabolic peptide.

This describes published preclinical research literature and is provided for research background only — it is not a claim about human aging outcomes, and REVIVE LAB UAE makes no anti-aging or longevity therapeutic claim for any product it sells.